Skip to Main Content
TABLE 1

Descriptive information of 1,304 white DCCT subjects, separately by treatment group

ConventionalIntensive
Sex (n  
    Male 363 332 
    Female 304 305 
Cohort (n  
    Primary prevention 344 307 
    Secondary intervention 323 330 
Age at DCCT baseline (years) 26.5 ± 7.1 27.2 ± 7.1 
Duration in the DCCT (years) 6.2 ± 1.6 6.3 ± 1.7 
Eligibility A1C (%) 9.00 ± 1.61 9.07 ± 1.58 
A1C measures obtained* 26 ± 7 (5–40) 63 ± 21 (3–103) 
Mean A1C (%)* 9.06 ± 1.24 7.22 ± 0.93 
Mean daily glucose from seven-point capillary profile (mg/dl)* 231 ± 80 156 ± 50 
Stimulated C-peptide at DCCT baseline (pmol/ml) 0.117 ± 0.119 0.111 ± 0.119 
ConventionalIntensive
Sex (n  
    Male 363 332 
    Female 304 305 
Cohort (n  
    Primary prevention 344 307 
    Secondary intervention 323 330 
Age at DCCT baseline (years) 26.5 ± 7.1 27.2 ± 7.1 
Duration in the DCCT (years) 6.2 ± 1.6 6.3 ± 1.7 
Eligibility A1C (%) 9.00 ± 1.61 9.07 ± 1.58 
A1C measures obtained* 26 ± 7 (5–40) 63 ± 21 (3–103) 
Mean A1C (%)* 9.06 ± 1.24 7.22 ± 0.93 
Mean daily glucose from seven-point capillary profile (mg/dl)* 231 ± 80 156 ± 50 
Stimulated C-peptide at DCCT baseline (pmol/ml) 0.117 ± 0.119 0.111 ± 0.119 

Data are means ±SD and means ±SD (range) unless otherwise indicated. There were 667 individuals in the conventional group and 637 in the intensive group with genotype data.

*For the intensive group, values used were from DCCT year 1 onward, whereas in the conventional group, all DCCT values were used, and for A1C in the conventional group, quarterly values were used, while in the intensive group, monthly values were used.

Close Modal

or Create an Account

Close Modal
Close Modal